Spela Zupancic
Overview
Explore the profile of Spela Zupancic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grilc N, Stojanov S, Rijavec T, Lapanje A, Berlec A, Zupancic S
Int J Pharm
. 2025 Feb;
673:125327.
PMID: 39956409
Electrospun nanofibers have emerged as a promising platform for probiotic delivery, with bacterial preservation posing a significant challenge in formulation design. This study examined the preservation of bacteria in various...
2.
Plavec T, Zagar Soderznik K, Della Pelle G, Zupancic S, Vidmar R, Berlec A
Sci Rep
. 2025 Jan;
15(1):1768.
PMID: 39815011
Extracellular vesicles (EVs) are nanosized lipid bilayer particles released by various cellular organisms that carry an array of bioactive molecules. EVs have diagnostic potential, as they play a role in...
3.
Stojanov S, Plavec T, Zupancic S, Berlec A
Microb Cell Fact
. 2024 Dec;
23(1):333.
PMID: 39696572
Electrospun nanofibers offer a highly promising platform for the delivery of vaginal lactobacilli, providing an innovative approach to preventing and treating vaginal infections. To advance the application of nanofibers for...
4.
Grilc N, Kristl J, Zupancic S
Colloids Surf B Biointerfaces
. 2024 Nov;
245:114329.
PMID: 39486375
Probiotics and live therapeutic bacteria (LTB), their strictly regulated therapeutic counterpart, are increasingly important in treating and preventing biofilm-related diseases. This necessitates new approaches to (i) preserve bacterial viability during...
5.
Zidar A, Zupancic S, Kristl J, Jeras M
Int J Biol Macromol
. 2024 Oct;
282(Pt 3):137029.
PMID: 39481718
Nanofiber safety, especially immunogenicity, is important for their successful translation to clinical setting. This study provides a comprehensive evaluation of how nanofiber physical properties influence immune cells cultured on them,...
6.
Zidar A, Zupancic S, Kristl J, Jeras M
Int J Pharm
. 2023 Dec;
650:123696.
PMID: 38086494
Immunological safety of nanofibers remains poorly reported within the scientific literature and lacks specific in vitro testing models distinct from those used to test nanoparticles. To address the challenges of...
7.
Casula L, Zidar A, Kristl J, Jeras M, Kralj S, Fadda A, et al.
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111731
Conventional treatments for chronic wounds are often ineffective, thus new therapeutic approaches are needed, such as the delivery of immunomodulatory drugs that can reduce inflammation, restore immune cell function, and...
8.
Grilc N, Zidar A, Kocbek P, Rijavec T, Colja T, Lapanje A, et al.
J Control Release
. 2023 Feb;
355:371-384.
PMID: 36738969
Biofilm-associated diseases such as periodontitis are widespread and challenging to treat which calls for new strategies for their effective management. Probiotics represent a promising approach for targeted treatment of dysbiosis...
9.
Olechno K, Grilc N, Zupancic S, Winnicka K
Materials (Basel)
. 2022 Aug;
15(15).
PMID: 35955221
Electrospinning is considered a simple and comprehensive technique to formulate ultrafine fibres by using an electric field. Polymeric nanofibers constitute promising materials in biomedical applications as drug delivery systems. For...
10.
Podborsek G, Zupancic S, Kaufman R, Surca A, Marsel A, Pavlisic A, et al.
Nanomaterials (Basel)
. 2022 Jul;
12(13).
PMID: 35808013
Titanium oxynitride carbon composite nanofibers (TiON/C-CNFs) were synthesised with electrospinning and subsequent heat treatment in ammonia gas. In situ four-probe electrical conductivity measurements of individual TiON/C-CNFs were performed. Additionally, the...